関連する実験動画
Updated: Aug 14, 2026

04:38
Assessment of Sexual Behavior of Male Mice
Published on: March 5, 2020
まとめ
雌ネズミの長期エストロゲン治療により排泄が誘発され,この能力はアンドロゲンに依存していないことを示した. この発見は,排泄パターンがこれまで理解されていたよりも雌性哺乳類でより一般的であることを示唆しています.
科学分野:
- 神経内分泌学の神経内分泌学
- 哺乳類の生殖行動について
背景:
- 哺乳類の雌性における性行為の表現は,ホルモン要因の影響を受けます.
- 女性の射精の可能性とその発達の起源は,依然として調査の分野です.
研究 の 目的:
- 雌ネズミの性行為に長期にわたるエストロゲン治療の影響を調査する.
- メスネズミの排泄パターンの発達におけるアンドロゲン被曝の役割を決定する.
主な方法:
- 成人したメスラットは,長期にわたるエストロゲン治療を受けた.
- 排泄を含む性的行動は,交尾中に観察されました.
- 下垂体とクリトールの縮を評価した.
- pituitary の背面にある脳の領域は,圧力の損傷を検査しました.
主要な成果:
- エストロゲン治療は雌ネズミの種特有の運動パターンを誘発した.
- 下垂体縮と隣接する脳領域への圧力損傷が観察されました.
- エストロゲン治療によってクリトールの縮は誘発されませんでした.
- 排泄パターンは,生理周期のアンドロゲン被曝なしのメスラットで実証されました.
結論:
- 女性の射精能力は,胎内アンドロゲン被曝に依存しない.
- エストロゲン治療は,成人雌ネズミの排泄パターンの発現を容易にすることができます.
- 排泄パターンは,これまで認識されていたよりも雌性哺乳類でより広範に広がっている可能性があります.
関連する概念動画
Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Urinary Tract Calculi III: Medical Management
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Urinary Tract Calculi VI: Surgical Management
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...

